Close Menu

GE Healthcare

The partners are preparing to release two updates to Navify Tumor Board that support automatic importation of structured Foundation Medicine test reports.

The cancer genetics testing provider acquired its new business unit from GE Healthcare.

By buying Clarient, NeoGenomics hopes to move closer to its goal of becoming America's top cancer genetic testing lab.

NeoGenomics and GE Healthcare will also collaborate on a bioinformatics initiative for personalized oncology.

The deal gives Axiogenesis access to IP that will allow it to commercialize stem cell-derived assays and disease models for use in drug discovery.

The licenses provide non-exclusive access to the IP for research applications.

General Electric has been awarded

NEW YORK (GenomeWeb) – GE Healthcare today announced a deal between its affiliate Clarient Diagnostic Services and GlaxoSmithKline to create a network of clinical laboratories to identify genetic mutations associated with different tumor types.

Title: Treatment of Cancer by Inhibition of IGFBPs and Clusterin
Patent Number: 8,835,401
Filed: May 29, 2013

Pages

Russian CRISPR researcher moves along with plans to ultimately alter the genes of embryos of deaf couples, though awaits regulatory approval, Nature News reports.

University of California, San Francisco, researchers have uncovered a gene mutations that appears to make a father-son duo more efficient sleepers.

NPR reports a large health insurer has begun to cover some pharmacogenetic tests for psychiatric drugs.

In PLOS this week: genome-wide association study of non-syndromic orofacial cleft subtypes, epigenetic and transcriptomic analysis of pancreatic ductal adenocarcinoma, and more.